Login / Signup

Anticoagulation of a Percutaneous Left Ventricular Assist Device Using a Low-Dose Heparin Purge Solution Protocol: A Case Series.

Andrea Sikora NewsomeAshley TaylorSeth Garner
Published in: Journal of pharmacy practice (2019)
The use of a low-dose anticoagulation protocol of heparin 25 units/mL in dextrose 20% as needed warrants further evaluation.
Keyphrases
  • low dose
  • venous thromboembolism
  • left ventricular assist device
  • atrial fibrillation
  • high dose
  • randomized controlled trial
  • growth factor
  • minimally invasive
  • radiofrequency ablation